BASF's New China Plant Puts Strain on Balance Sheet -- Market Talk

Dow Jones
Sep 18

1512 GMT - BASF's 10-billion-euro investment in a new China plant has put considerable strain on its balance sheet, compromising the German chemical giant's dividend, BofA Securities analyst Matthew Yates says in a note. "We question the contribution BASF's new China plant will make to profits as it ramps up amidst depressed market conditions," he says. According to Yates, the plant also risks cannibalizing the European footprint due to shifting trade flows. This could lead to the need for more restructuring, "which BASF appears reluctant to contemplate, or can ill afford to do." BofA downgrades BASF to underperform from neutral. Shares trade 1.2% lower at 42.97 euros. (sarah.sloat@wsj.com)

 

(END) Dow Jones Newswires

September 18, 2025 11:12 ET (15:12 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10